Etiology and pathogenesis of basal cell carcinoma

1. Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 2002;8:939-44.10.1053/jlts.2002.35551Search in Google Scholar

2. Al Junidi KF, Paravina M, Katić V, Mitsa P. Basal cell carcinoma: a retrospective clinicopathological analysis of 100 cases derived from the histopathological registry of the Institute of pathology in Niš. Serb J Dermatol Venereol 2012;4(1):18-30.Search in Google Scholar

3. Popadić S, Tanasilović S, Živanović D, Medenica Lj. Genital superficial basal cell carcinoma: a case report. Serb J Dermatol Venereol 2010;2(3):106-9.Search in Google Scholar

4. Prado R, Francis SO, Mason MN, Wing G, Gamble RG, Dellavalle R. Nonmelanoma skin cancer chemoprevention. Dermatol Surg 2011;37(11):1566-78.10.1111/j.1524-4725.2011.02108.xSearch in Google Scholar

5. Roš T, Gajić B, Rajić N, Ivkov-Simić M, Gajinov Z. Basal cell carcinoma: a frequent challenge. Serb J Dermatol Venereol 2012;4(1):5-17.Search in Google Scholar

6. Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 1997;133:1263-70.10.1001/archderm.1997.03890460087010Search in Google Scholar

7. Tran H, Chen K, Shumack S. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2003;149(Suppl 66):50-2.10.1046/j.0366-077X.2003.05622.xSearch in Google Scholar

8. De Gruijl FR, Van Kranen HJ, Mullenders LH. UV-induces DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol 2001;63:19-27.10.1016/S1011-1344(01)00199-3Search in Google Scholar

9. Holíková Z, Massi D, Lotti T, Hercogová J. Insight into the pathogenesis of sporadic basal cell carcinoma. Int J Dermatol 2004;43:865-9.10.1111/j.1365-4632.2004.02319.xSearch in Google Scholar

10. Bodak N, Queille S, Avril MF, Bouadjar B, Drougard C, Sarasin A, et al. High levels of patched gene mutations in basal cell carcinomas from patients with xeroderma pigmentosum. Proc Natl Acad Sci USA 1999;9:5117-22.10.1073/pnas.96.9.5117Search in Google Scholar

11. Soehnge H, Ouhtit A, Ananthaswamy ON. Mechanisms of induction of skin cancer by UV radiation. Front Biosci 1997;2:538-51.10.2741/A211Search in Google Scholar

12. Vitasa BC, Taylor HR, Strickland PT, Rosenthal FS, West S, Abbey H, et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990;65:2811-7.10.1002/1097-0142(19900615)65:12<2811::AID-CNCR2820651234>3.0.CO;2-USearch in Google Scholar

13. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol 1996;35:1012-3.10.1016/S0190-9622(96)90139-5Search in Google Scholar

14. Corona R, Dogliotti E, D’Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001;137:1162-8.10.1001/archderm.137.9.1162Search in Google Scholar

15. Ramani ML, Bennett RG. High prevalence of skin cancer in World War II servicemen stationed in the Pacific theater. J Am Acad Dermatol 1993;28(5 Pt 1):733-7.10.1016/0190-9622(93)70102-YSearch in Google Scholar

16. Marks R. An overview of skin cancers: incidence and causation. Cancer 1995;75(2 Suppl): 607-12.10.1002/1097-0142(19950115)75:2+<607::AID-CNCR2820751402>3.0.CO;2-8Search in Google Scholar

17. Stern RS, Weinstein MC, Baker SG. Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol 1986;122:537-45.10.1001/archderm.1986.01660170067022Search in Google Scholar

18. Hemminki K, Zhang H, Czene K. Time trends and familial risks in squamous cell carcinoma of the skin. Arch Dermatol 2003;139:885-9.10.1001/archderm.139.7.885Search in Google Scholar

19. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002;94:224-6.10.1093/jnci/94.3.224Search in Google Scholar

20. Boyd AS, Shyr Y, King LE Jr. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol 2002;46:706-9.10.1067/mjd.2002.120467Search in Google Scholar

21. Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000;136:1007-11.10.1001/archderm.136.8.1007Search in Google Scholar

22. Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res 2002;157:410-8.10.1667/0033-7587(2002)157[0410:SCAXRT]2.0.CO;2Search in Google Scholar

23. Stante M, Salvini C, De Giorgi V, Carli P. Multiple synchronous pigmented basal cell carcinomas following radiotherapy for Hodgkin’s disease. Int J Dermatol 2002;41:208-11.10.1046/j.1365-4362.2002.01453.xSearch in Google Scholar

24. Lei U, Masmas TN, Frentz G. Occupational non-melanoma skin cancer. Acta Dermatol Venereol 2001;81:415-7.10.1080/000155501317208354Search in Google Scholar

25. Wong SS, Tan KC, Goh CL. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol 1998;38(2 PT 1):179-85.10.1016/S0190-9622(98)70596-1Search in Google Scholar

26. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study. Cancer 1994;73:2759-64.Search in Google Scholar

27. Barr BB, Benton EC, McLaren K, Smith IW, Bunney MH, Smith IW, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989;1:124-9.10.1016/S0140-6736(89)91143-4Search in Google Scholar

28. Weinstock MA, Coulter S, Bates J, Bogaars HA, Larson PL, Burmer GC. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy. Arch Dermatol 1995;131:701-4.10.1001/archderm.1995.01690180077014Search in Google Scholar

29. Tilli CMLJ, Van Steensel MA, Krekels GAM, Neumann HAM, Ramaekers FCS. Molecular aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol 2005;152:1108-24.10.1111/j.1365-2133.2005.06587.xSearch in Google Scholar

30. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154-66.10.1159/000028396Search in Google Scholar

31. Lear JT, Strange RC, Fryer AA. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst 1997;89:454-5.10.1093/jnci/89.6.454Search in Google Scholar

32. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A, et al. Polymorphism at the glutathione transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 1996;56:1974-7.Search in Google Scholar

33. Lear JT, Heagerty AH, Smith A, Bowers B, Payne CR, Smith CA, et al. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis 1996;17:1891-6.10.1093/carcin/17.9.1891Search in Google Scholar

34. Ramachandran S, Hoban PR, Ichii-Jones F, Pleasants L, Ali- Osman F, Lear JT, et al. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumors. Pharmacogenetics 2000;10:545-56.10.1097/00008571-200008000-00008Search in Google Scholar

35. Cleaver JE. Ultraviolet photobiology: its early roots and insights into DNA repair. DNA Repair (Amst) 2002;1:977-9.10.1016/S1568-7864(02)00162-3Search in Google Scholar

36. Segerbäck D, Strozyk M, Snellman E, Hemminki K. Repair of UV dimers in skin DNA of patients with basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008; 17: 2388-92.10.1158/1055-9965.EPI-08-0248Search in Google Scholar

37. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, et al. Positional cloning of the Werner’s syndrome gene. Science 1996;272:258-62.10.1126/science.272.5259.258Search in Google Scholar

38. Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, et al. The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell 1995;83:655-66.10.1016/0092-8674(95)90105-1Search in Google Scholar

39. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.10.1126/science.19787571978757Search in Google Scholar

40. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita Nature 2001;413:432-5.Search in Google Scholar

41. Wicking C, Smyth I, Bale A. The hedgehog signalling pathway in tumorigenesis and development. Oncogene 1999;18:7844-51.10.1038/sj.onc.120328210630637Search in Google Scholar

42. Zibat A, Uhmann A, Nitzki F, Wijgerde M, Frommhold A, Heller T, et al. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional PTCH knockouts. Carcinogenesis 2009;30:918-26.10.1093/carcin/bgp06819321799Search in Google Scholar

43. Dicker T, Siller G, Saunders N. Molecular and cellular biology of basal cell carcinoma. Australas J Dermatol 2002;43:241-6.10.1046/j.1440-0960.2002.00609.x12423429Search in Google Scholar

44. Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003;424:801-5.10.1038/nature0180212917691Search in Google Scholar

45. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003;424:793-6.10.1038/nature0180312917689Search in Google Scholar

46. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51(23 Pt 1):6304-11.Search in Google Scholar

47. Ronen D, Schwartz D, Teitz Y, Goldfinger N, Rotter V. Induction of HL-60 cells to undergo poptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ 1996;7: 21-30.Search in Google Scholar

48. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993;8:203-7.Search in Google Scholar

49. Auepemkiate S, Boonyaphiphat P, Thongsuksai P. P53 expression related to the aggressive infiltrative histopathological feature of basal cell carcinoma. Histopathology 2002;40: 568-73.10.1046/j.1365-2559.2002.01393.x12047769Search in Google Scholar

50. Rosenstein BS, Phelps RG, Weinstock MA, Bernstein JL, Gordon ML, Rudikoff D, et al. p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochem Photobiol 1999;70:798-806.10.1111/j.1751-1097.1999.tb08285.xSearch in Google Scholar

51. Kim MY, Park HJ, Baek SC, Byun DG, Houh D. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 2002;29:1-9.10.1016/S0923-1811(01)00170-0Search in Google Scholar

52. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science 1996;271:1744-7.10.1126/science.271.5256.1744Search in Google Scholar

53. Liefer KM, Koster MI, Wang XJ, Yang A, McKeon F, Roop DR. Down-regulation of p63 is required for epidermal UV-Binduced apoptosis. Cancer Res 2000;60:4016-20.Search in Google Scholar

54. Rodriguez-Villanueva J, Colome MI, Brisbay S, McDonnell TJ. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers. Pathol Res Pract 1995;191:391-8.10.1016/S0344-0338(11)80724-7Search in Google Scholar

55. Verhaegh ME, Sanders CJ, Arends JW, Neumann HA. Expression of the apoptosis-suppressing protein Bcl-2 in nonmelanoma skin cancer. Br J Dermatol 1995; 132: 740-4.10.1111/j.1365-2133.1995.tb00719.xSearch in Google Scholar

56. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol 1999;21:332-6.10.1097/00000372-199908000-00004Search in Google Scholar

57. Rossen K, Karabulut Thorup A, Hou-Jensen K, Krag Jacobsen G. BAX protein is not expressed by basal cell carcinomas. Br J Dermatol 1998;139:472-4.10.1046/j.1365-2133.1998.02412.xSearch in Google Scholar

58. Alamartine E, Berthoux P, Mariat C, Cambazard F, Berthoux F. Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 2003;120:99-103.10.1046/j.1523-1747.2003.12016.xSearch in Google Scholar

59. Grimbaldeston M, Pearce AL, Robertson BO, Coventry BJ, Marshman G, Finlay-Jones JJ, et al. Association between melanoma and dermal mast cell prevalence in sun-unexposed skin. Br J Dermatol 2004;150:895-903.10.1111/j.1365-2133.2004.05966.xSearch in Google Scholar

60. Grimbaldeston MA, Skov L, Finlay-Jones JJ, Hart PH. Increased dermal mast cell prevalence and susceptibility to development of basal cell carcinoma in humans. Methods 2002;28:90-6.10.1016/S1046-2023(02)00213-XSearch in Google Scholar

61. Grimbaldeston MA, Skov L, Finlay-Jones JJ, Hart PH. Squamous cell carcinoma is not associated with high dermal mast cell prevalence in humans. J Invest Dermatol 2002;119: 1204-6.10.1046/j.1523-1747.2002.19511.xSearch in Google Scholar

62. Ch`ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol 2006;19:149-59.10.1038/modpathol.3800474Search in Google Scholar

63. Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 2002;168:2255-63.10.4049/jimmunol.168.5.2255Search in Google Scholar

64. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppresion. Eur J Dermatol 2003;13:515-23.Search in Google Scholar

65. Kripke ML. Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res 1994;54:6102-5.Search in Google Scholar

66. Streilein JW. Sunlight and skin-associated lymphoid tissues (SALT): if UVB is the trigger and TNF alpha is its mediator, what is the message? J Invest Dermatol 1993;100:47S-52S.10.1111/1523-1747.ep12355578Search in Google Scholar

67. Ratner D, Lowe L, Johnson TM, Fader DJ. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 2000;88:1605-13.10.1002/(SICI)1097-0142(20000401)88:7<1605::AID-CNCR15>3.0.CO;2-YSearch in Google Scholar

68. Granstein RD. Cytokines and photocarcinogenesis. Photochem Photobiol 1996;63:390-4.10.1111/j.1751-1097.1996.tb03052.xSearch in Google Scholar

69. Fortis C, Foppoli M, Gianotti L, Galli L, Citterio G, Consogno G, et al. Increased interleukin-10 serum levels in patients with solid tumors. Cancer Lett 1996;104:1-5.10.1016/0304-3835(96)04213-9Search in Google Scholar

70. Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, et al. Risk of cancer other than Kaposi’s sarcoma and non-Hodgkin’s lymphoma in persons with AIDS in Italy. Cancer AIDS Registry Linkage Study. Br J Cancer 1998;78:966-70.10.1038/bjc.1998.610Search in Google Scholar

71. Sitz KV, Keppen M, Johnson DF. Metastatic basal cell carcinoma in acquired immunodeficiency syndrome-related complex. 1987;257:340-3.Search in Google Scholar

72. Cabrera T, Garrido V, Concha A, Martín J, Esquivias J, Oliva MR, et al. HLA molecules in basal cell carcinoma of the skin. Immunobiology 1992;185:440-52.10.1016/S0171-2985(11)80086-0Search in Google Scholar

73. Garcia-Plata D, Mozos E, Sierra MA, Pena J, Solana R. HLA expression in basal cell carcinomas. Invasion Metastasis 1991;11:166-73.Search in Google Scholar

74. Bavinck JN, Bastiaens MT, Marugg ME, Beckers RC, Westendorp RG, Vermeer BJ, et al. Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba. Arch Dermatol 2000;136:1019-22.10.1001/archderm.136.8.1019Search in Google Scholar

75. Rompel R, Petres J, Kaupert K, Müller-Eckhardt G. HLA phenotypes and multiple basal cell carcinomas. Dermatology 1994;189:222-4.10.1159/000246842Search in Google Scholar

76. Rompel R, Petres J, Kaupert K, Müeller-Eckhardt G. Human leukocyte antigens and multiple basal cell carcinomas. Recent Results Cancer Res 1995;139:297-302.10.1007/978-3-642-78771-3_22Search in Google Scholar

77. Czarnecki D, Lewis A, Nicholson I, Tait B, Nash C. HLA-DR1 is not a sign of poor prognosis for the development of multiple basal cell carcinomas. J Am Acad Dermatol 1992;26:717-9.10.1016/0190-9622(92)70099-2Search in Google Scholar

78. Lacour JP. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 2002;146(Suppl 61):17-9.10.1046/j.1365-2133.146.s61.5.x11966727Search in Google Scholar

79. Owens DM, Watt FM. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 2003;3:444-51.10.1038/nrc109612778134Search in Google Scholar

80. Miller SJ, Sun TT, Lavker RM. Hair follicles, stem cells and skin cancer. J Invest Dermatol 1993;100:288S-94S.10.1111/1523-1747.ep124701698440907Search in Google Scholar

81. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, et al. Defining the epithelial stem cell niche in skin. Science 2004;303:359-63.10.1126/science.1092436240592014671312Search in Google Scholar

82. Lee Y, Miller HL, Russell HR, Boyd K, Curran T, McKinnon PJ. Patched 2 modulates tumorigenesis in Patched1 heterozygous mice. Cancer Res 2006;66:6964-71.10.1158/0008-5472.CAN-06-050516849540Search in Google Scholar

83. Walsh N, Ackerman AB. Infundibulocystic basal cell carcinoma: a newly described variant. Mod Pathol 1990;3:599-608.Search in Google Scholar

84. Gho CG, Braun JE, Tilli CM, Neumann HA, Ramaekers FC. Human follicular stem cells: their presence in plucked hair and follicular cell culture. Br J Dermatol 2004;150:860-8.10.1111/j.1365-2133.2004.05862.x15149497Search in Google Scholar

85. Miller SJ, Wei ZG, Wilson C, Dzubow L, Sun TT, Lavker RM. Mouse skin is particularly susceptible to tumor initiation during early anagen of the hair cycle: possible involvement of hair follicle stem cells. J Invest Dermatol 1993;101:591-4.10.1111/1523-1747.ep123660458409528Search in Google Scholar

86. Bernemann TM, Podda M, Wolter M, Boehncke WH. Expression of the basal cell adhesion molecule (B-CAM) in normal and diseased human skin. J Cutan Pathol 2000;27:108-11.10.1034/j.1600-0560.2000.027003108.x10728810Search in Google Scholar

87. Kanitakis J, Bourchany D, Faure M, Claudy A. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol 1999;9:363-5.Search in Google Scholar

88. Quinn AG, Perkins W. Non-melanoma skin cancer and other epidermal skin tumours. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. 6th ed. Oxford: Blackwell Publishing Ltd; 2010. p. 52.1-48. 10.1002/9781444317633.ch52Search in Google Scholar